← Open Payments lookup

JEFFREY MARTZ: Open Payments

NPI 1376013771 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,313 in 73 payments from 21 companies in 2025. Trend: 2023 $1,245 · 2024 $515 · 2025 $1,313

Food & beverage: $1,313
CompanyPaymentsAmount
ABBVIE INC.11$218
Novo Nordisk Inc8$143
Otsuka America Pharmaceutical, Inc.8$140
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$135
Lilly USA, LLC6$108
PFIZER INC.5$97
Astellas Pharma US Inc3$57
AstraZeneca Pharmaceuticals LP3$49
Amgen Inc.3$45
Boehringer Ingelheim Pharmaceuticals, Inc.2$41

Products named: VRAYLAR, REXULTI, CAPLYTA, MOUNJARO, Ozempic, NURTEC ODT, Veozah, QULIPTA.

Industry payments across TX — which companies pay providers there.